Display options
Share it on

Case Rep Oncol. 2021 Mar 08;14(1):365-370. doi: 10.1159/000514048. eCollection 2021.

Long-Lasting Complete Remission of Small-Cell Carcinoma of the Pancreas with Carboplatin and Etoposide Complicated by Gallbladder Adenocarcinoma Diagnosed during Follow-Up.

Case reports in oncology

Konstantinos Tyriakidis, Sylvia Stadlmann, Stefanie Pederiva

Affiliations

  1. Department of Medical Oncology, Cantonal Hospital Baden, Baden, Switzerland.
  2. Institute of Pathology, Cantonal Hospital Baden, Baden, Switzerland.

PMID: 33776730 PMCID: PMC7983696 DOI: 10.1159/000514048

Abstract

Small-cell carcinoma of the pancreas (PSCC) is a highly aggressive neoplasia with a dismal prognosis. It is extremely rare, with only a few cases reported in the literature. There is a paucity of clinical data to guide management and since the disease is mainly diagnosed at an advanced stage standard treatment consists of chemotherapy based upon treatment protocols used for small-cell lung cancer. We report the case of a female diagnosed with PSCC who achieved complete clinical remission after treatment with carboplatin and etoposide. During a 3-year follow-up the patient developed a gallbladder adenocarcinoma that was treated by surgical resection but relapsed within 20 months with widespread hematogenous metastasis.

Copyright © 2021 by S. Karger AG, Basel.

Keywords: Carboplatin; Complete remission; Etoposide; Pancreatic cancer; Small-cell carcinoma

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

  1. Cancer. 1989 Nov 15;64(10):2007-9 - PubMed
  2. Abdom Imaging. 2000 Jul-Aug;25(4):409-19 - PubMed
  3. Pancreas. 2016 Nov;45(10):1461-1466 - PubMed
  4. J Gastroenterol. 2009;44(5):432-8 - PubMed
  5. Case Rep Oncol. 2017 Aug 9;10(2):720-725 - PubMed
  6. Pancreatology. 2004;4(6):521-6 - PubMed
  7. J Immunother Cancer. 2018 Jul 9;6(1):66 - PubMed
  8. Gan To Kagaku Ryoho. 2019 Dec;46(13):2312-2314 - PubMed

Publication Types